Clinically studied for greater weight loss than GLP-1 alone
*Correspondence: Donato Cappetta, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
A new study, which appeared in The condition, called nonarteritic anterior ischemic optic neuropathy (NAION), affects around The new study finds that people with diabetes who were prescribed semaglutide which is marketed as Ozempic and Wegovy, among other names were more than four times more likely to develop NAION compared with people with diabetes on other medications
Before their cellular effects can be fully explained, more thorough studies are required to fully understand the signaling pathways affected by dual- and triagonism
By Lisa Spear When sleep specialist Michelle Primeau, MD, takes out her prescription pad for a patient with insomnia, she is likely not prescribing a sleeping pill like Ambien but directing patients to a software program instead
It has many health benefits
